Perioperative Acute Kidney Injury.


Journal

Anesthesiology
ISSN: 1528-1175
Titre abrégé: Anesthesiology
Pays: United States
ID NLM: 1300217

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 7 11 2019
medline: 14 5 2020
entrez: 6 11 2019
Statut: ppublish

Résumé

Perioperative organ injury is among the leading causes of morbidity and mortality of surgical patients. Among different types of perioperative organ injury, acute kidney injury occurs particularly frequently and has an exceptionally detrimental effect on surgical outcomes. Currently, acute kidney injury is most commonly diagnosed by assessing increases in serum creatinine concentration or decreased urine output. Recently, novel biomarkers have become a focus of translational research for improving timely detection and prognosis for acute kidney injury. However, specificity and timing of biomarker release continue to present challenges to their integration into existing diagnostic regimens. Despite many clinical trials using various pharmacologic or nonpharmacologic interventions, reliable means to prevent or reverse acute kidney injury are still lacking. Nevertheless, several recent randomized multicenter trials provide new insights into renal replacement strategies, composition of intravenous fluid replacement, goal-directed fluid therapy, or remote ischemic preconditioning in their impact on perioperative acute kidney injury. This review provides an update on the latest progress toward the understanding of disease mechanism, diagnosis, and managing perioperative acute kidney injury, as well as highlights areas of ongoing research efforts for preventing and treating acute kidney injury in surgical patients.

Identifiants

pubmed: 31687986
doi: 10.1097/ALN.0000000000002968
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

180-204

Subventions

Organisme : NHLBI NIH HHS
ID : P01 HL114457
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK097075
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL133900
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL119837
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL109233
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK109574
Pays : United States

Commentaires et corrections

Type : CommentIn

Auteurs

Sam D Gumbert (SD)

From the Department of Anesthesiology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas (S.D.G., M.L.J., N.V., S.J.G., C.Y.W., H.K.E.) the Department of Anesthesiology, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany (F.K.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH